|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force显示文摘 | McKenney JM Davidson MH Jacobso TA | | 0，，8： | 1 |
| 2 | Efficacy and safety of torcetrapib,a novel cholesteryl ester transfer protein inhibitor,in individuals with below-average high-density lipoprotein cholesterol levels显示文摘 | Davidson MH Mckenney JM Shear CL | 2006 | J Am Coll Cardiol2006，48，9： | 1 |
| 3 | Efficacy and safety of torcetrapib,a novel cholesteryl ester transfer protein inhibitor,in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin显示文摘 | Mckenney JM Davidson MH Shear CL | 2006 | J Am Coll Cardiol2006，48，9： | 1 |
| 4 | Safety andefficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/ REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy显示文摘 | McKenney JM Koren MJ Kereiakes DJ | 2012 | J Am Coll Cardiol2012，59，25： | 1 |
| 5 | Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia显示文摘 | Roth EM McKenney JM Hanotin C | 2012 | N Engl J Med2012，367，20： | 1 |
| 6 | Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease,SAR236553/REGN727,in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy显示文摘 | McKenney JM Koren MJ Kereiakes DJ | | 0，，： | 1 |
| 7 | Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine proteaae, SAR236553/REGN727, in patients with primary hyperoholesterolemia receiving ongoing stable atorvastatin therapy显示文摘 | McKENNEY JM KOREN MJ KEREIAKES D J | 2012 | J Am Coil Car lid2012，59，25： | 1 |
| 8 | Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia显示文摘 | Roth EM McKenney JM Hanotin C | | 0，，： | 1 |
| 9 | Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia显示文摘 | ROTH EM McKENNEY JM HANOTIN C | 2012 | N Engl J Med2012，367，20： | 1 |
| 10 | Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia 显示文摘 | Roth EM McKenney JM Hanotin C | 2012 | N Engl J Med2012，367，20： | 1 |
| 11 | Comparative effects on lipid levels of combination therapywith a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study) 显示文摘 | MCKENNEY JM JONES PH BAYS HE | 2007 | Atherosclerosis2007，192，2： | 1 |
| 12 | Safety and efficacy of a monoclonal antibody to proprotein convertasesubtilisin/kexin type 9 serine protease, SAR236553/ REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy 显示文摘 | McKENNEY JM KOREN MJ KEREIAKES DJ | 2012 | J Am Coll Cardiol2012，59，25： | 1 |
| 13 | Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy 显示文摘 | McKenney JM Koren M J Kereiakes DJ | 2012 | J Am Coil Cardiol2012，59，25： | 1 |
| 14 | Atorvastatin with orwithout an antibody to PCSK9 in primary hypercholest- erolemia显示文摘 | ROTH EM McKENNEY JM HANOTIN C | 2012 | N Engl J Med2012，367，20： | 1 |
| 15 | Statin safety, an assessment using an ministrative claims database显示文摘 | Cziraky MJ Willey V J Mckenney JM | 2006 | Am J Cardiol2006，97，8： | 1 |
| 16 | Pharmacologic characteristics of statins 显示文摘 | Mckenney JM | 2003 | Clin Cardiol2003，26，11： | 1 |
| 17 | Safety consid erations with Fibrate therapy显示文摘 | Davidson MH Armani A McKenney JM | 2007 | Am J Cardiol2007，，： | 1 |
| 18 | Pharmacologic characteristics of statin显示文摘 | Mckenney JM | 2003 | Clin Cardiol2003，26，11： | 1 |
| 19 | Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force 显示文摘 | McKenney JM Davidson MH Jacobson TA | 2006 | Am J Cardiol2006，97，8： | 1 |
| 20 | Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisinlkexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy显示文摘 | McKenney JM Koren MJ Kereiakes DJ et aJ | 2012 | J Am Coll Cardiol2012，59，25： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员